Peripheral Neuropathies
Charcot-Marie-Tooth disease type 1A
Jun. 19, 2024
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
(A) Visual field testing of the left eye at presentation. In the visual field of the left eye, defects include an inferior nasal step and an inferior altitudinal defect to less visible stimuli. The right eye shows similar defects. (B) Following 1 week of treatment with prednisone 100 mg/day, repeat examination shows progression of visual field loss in the left eye. There is now a dense paracentral scotoma (likely an evolving cecocentral scotoma) and increased definition of the inferior nasal step. Also of note is the increasing constriction of isopters to the larger or brighter stimuli. (Contributed by Dr. Mark Duffy.)